4//SEC Filing
Sklawer Andrew D 4
Accession 0001214659-20-002730
CIK 0000819050other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:30 PM ET
Size
15.5 KB
Accession
0001214659-20-002730
Insider Transaction Report
Form 4
Sklawer Andrew D
COO and Secretary
Transactions
- Award
Restricted Stock Units
2020-03-16$1.54/sh+20,000$30,800→ 20,000 totalExercise: $1.54From: 2021-03-16Exp: 2030-03-15→ Common Stock (20,000 underlying)
Holdings
- 12,082
Stock Options
Exercise: $12.17From: 2015-04-22Exp: 2025-04-22→ Common Stock (12,082 underlying) - 34,521
Stock Options
Exercise: $16.45From: 2019-12-15Exp: 2028-12-15→ Common Stock (34,521 underlying) - 103,564
Stock Options
Exercise: $4.76From: 2020-08-30Exp: 2029-08-30→ Common Stock (103,564 underlying) - 2,984
Warrants
Exercise: $10.36From: 2019-08-30Exp: 2029-08-30→ Common Stock (2,984 underlying) - 83,206
Common Stock
- 17,260
Stock Options
Exercise: $6.37From: 2014-02-14Exp: 2024-02-14→ Common Stock (17,260 underlying) - 12,082
Stock Options
Exercise: $12.17From: 2015-12-23Exp: 2025-12-23→ Common Stock (12,082 underlying) - 8,630
Stock Options
Exercise: $12.17From: 2016-12-15Exp: 2026-12-15→ Common Stock (8,630 underlying) - 3,624
Stock Options
Exercise: $16.69From: 2018-11-27Exp: 2027-12-15→ Common Stock (3,624 underlying)
Documents
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001782334
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:30 PM ET
- Size
- 15.5 KB